Table 1 Baseline Characteristics
Characteristic | Number of patients [N] |
|---|---|
Age (years), median (range) | 64 (42-79) |
Gender | |
 Male | 42 |
 Female | 13 |
Pathological grade | |
 G 1-2 | 21 |
 G 3 | 11 |
 Gx/NA | 23 |
Pathology | |
 Squamous cell | 52 |
 Adenoid cell | 1 |
 CIS/NA | 1/1 |
T stage | |
  ≤ 2 | 12 |
 3-4 | 42 |
 Tx | 1 |
N stage | |
 N 0 | 18 |
 N 1-3 | 37 |
 TNM stage | |
 I-II | 20 |
 III | 34 |
 NA | 1 |
Radiation dose (Gy) | |
  < 56 | 26 |
  ≥ 56 | 29 |
Radiotherapy technique | |
 3D | 14 |
 IMRT | 24 |
 Tomotherapy | 17 |
Induction chemotherapiy | |
 Yes | 32 |
 No | 23 |
Concurrent chemotherapy | |
 Yes | 51 |
 No | 4 |
Acute Tox ≥ Grade 3 | |
 Dysphagia | 8 |
 Skin | 3 |
 Pain | 7 |
 Haematological | 5 |
Chronic Dysphagia | |
 Grade 1-2 | 30 |
 Grade 3-4 | 5 |
 NA | 20 |
Patients by center | |
 Bern University Hospital | 16 |
 Hôpitaux Universitaires de Genève | 7 |
 Centre Hospitalier Universitaire Vaudois | 16 |
 Kantonsspital St.Gallen | 16 |